4//SEC Filing
Glanzman Robert 4
Accession 0001562180-21-003058
CIK 0001822791other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 5:16 PM ET
Size
5.7 KB
Accession
0001562180-21-003058
Insider Transaction Report
Form 4
Clene Inc.CLNN
Glanzman Robert
Chief Medical Officer
Transactions
- Award
Stock Options (Right to buy)
2021-04-30+95,000→ 95,000 totalExercise: $9.00Exp: 2031-04-30→ Common Stock (95,000 underlying)
Footnotes (1)
- [F1]This option was granted on April 30, 2021 under the Clene Inc. 2020 Stock Plan. The options vest with respect to the first 25% on May 31, 2022 and then in 36 equal installments of 1/48th of the balance on the last day of each calendar month, beginning June 30, 2022, until fully vested
Documents
Issuer
Clene Inc.
CIK 0001822791
Entity typeother
Related Parties
1- filerCIK 0001835428
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 5:16 PM ET
- Size
- 5.7 KB